{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:13:36Z","timestamp":1791195216746,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008484","name":"Paavo Nurmen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.atherosclerosis.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,10,16]],"date-time":"2011-10-16T04:50:55Z","timestamp":1318740655000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves"],"prefix":"10.1016","volume":"220","author":[{"given":"Virva","family":"Pohjolainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erja","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panu","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"N\u00e4p\u00e4nkangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Leskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauli","family":"Ohukainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Aro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatu","family":"Juvonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Ruskoaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Rys\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0005","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/hrt.2007.134783","article-title":"Aortic valve calcification: basic science to clinical practice","volume":"95","author":"Akat","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0015","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0046-8177(03)00245-4","article-title":"Angiogenesis is involved in the pathogenesis of non-rheumatic aortic valve stenosis","volume":"34","author":"Soini","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2009.03.108","article-title":"Molecular and cellular mechanisms of aortic stenosis","volume":"135","author":"Yetkin","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.humpath.2008.04.015","article-title":"Non-collagenous bone matrix proteins as a part of calcific aortic valve disease regulation","volume":"39","author":"Pohjolainen","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0003-4975(03)00529-0","article-title":"Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis","volume":"76","author":"Satta","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00392-004-1021-0","article-title":"Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis","volume":"93","author":"Kaden","year":"2004","journal-title":"Z Kardiol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0955-0674(02)00361-7","article-title":"Matricellular proteins: extracellular modulators of cell function","volume":"14","author":"Bornstein","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0045","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9440(10)61698-7","article-title":"Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis","volume":"159","author":"Jian","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0050","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/hrt.2005.086595","article-title":"Distribution of SPARC during neovascularisation of degenerative aortic stenosis","volume":"92","author":"Charest","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0055","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.biocel.2004.01.004","article-title":"The thrombospondins","volume":"36","author":"Adams","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12079-009-0077-z","article-title":"The role of thrombospondins in wound healing, ischemia, and the foreign body reaction","volume":"3","author":"Kyriakides","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0065","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.biocel.2004.01.012","article-title":"The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury","volume":"36","author":"Bornstein","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12079-009-0070-6","article-title":"Thrombospondins in the heart: potential functions in cardiac remodeling","volume":"3","author":"Schellings","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1742-7843.2010.00564.x","article-title":"Metoprolol treatment lowers thrombospondin-4 expression in rats with myocardial infarction and left ventricular hypertrophy","volume":"107","author":"Mustonen","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12079-009-0074-2","article-title":"The interaction of thrombospondins with extracellular matrix proteins","volume":"3","author":"Tan","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0085","doi-asserted-by":"crossref","first-page":"37110","DOI":"10.1074\/jbc.M007223200","article-title":"Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains","volume":"275","author":"Narouz-Ott","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.106.685743","article-title":"Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis","volume":"116","author":"Peltonen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0095","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.RES.0000238387.85144.92","article-title":"Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart","volume":"99","author":"Tenhunen","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00109-009-0443-6","article-title":"NF-kappa B blockade upregulates Bax TSP-1, and TSP-2 expression in rat granulation tissue","volume":"87","author":"De Stefano","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0105","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1074\/jbc.M110572200","article-title":"Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B","volume":"277","author":"Sizemore","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.matbio.2003.09.004","article-title":"Thrombospondin 2 levels are increased in aged mice: consequences for cutaneous wound healing and angiogenesis","volume":"22","author":"Agah","year":"2004","journal-title":"Matrix Biol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0110","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCULATIONAHA.109.863266","article-title":"Absence of thrombospondin-2 causes age-related dilated cardiomyopathy","volume":"120","author":"Swinnen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0120","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.4049\/jimmunol.178.9.5930","article-title":"Interactions between CD47 and thrombospondin reduce inflammation","volume":"178","author":"Lamy","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1242\/dev.117.1.347","article-title":"The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo","volume":"117","author":"Tucker","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0130","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1083\/jcb.140.2.419","article-title":"Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis","volume":"140","author":"Kyriakides","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0135","doi-asserted-by":"crossref","first-page":"26784","DOI":"10.1016\/S0021-9258(19)74381-6","article-title":"Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity","volume":"268","author":"Murphy-Ullrich","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/path.850","article-title":"Expression of MMP2, MMP9, MT1-MMP TIMP1, and TIMP2 mRNA in valvular lesions of the heart","volume":"194","author":"Soini","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0145","doi-asserted-by":"crossref","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappa B family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.atherosclerosis.2011.10.003_bib0150","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/ATVBAHA.108.182394","article-title":"Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix","volume":"29","author":"Yip","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011009919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011009919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:32:38Z","timestamp":1758155558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011009919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0021915011009919"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.10.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}